Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

NCT03067831 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Stem Cells Arabia